William J. Plovanic - 15 Oct 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Reporting relationship: Director
Issuer ticker: TELA
Reported as of: 15 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Oct 2026, 17:07:13 UTC
Prior SEC filing: 17 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Megan Smeykal, Attorney-in-Fact

Filing notes and source

Key filing fact

William J. Plovanic filed Form 4 for TELA Bio, Inc. (TELA) on 19 Oct 2026.

Key facts

This page summarizes William J. Plovanic's Form 4 filing for TELA Bio, Inc. (TELA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Oct 2026, 17:07.

Change

Previous filing in this sequence was filed on 17 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001685640 Primary reporting owner

Plovanic William J.

Relationship: Director
Address: C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN
Signature: /s/ Megan Smeykal, Attorney-in-Fact
Signature date: 19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Award

Transaction value
Shares: +16,089
Change %: +36%
Price: $1.01^*
Shares after: 60,619
Date: 15 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested.